Sign inCreate account

Report workspace tools

NCT01773083TERMINATEDanonymous

Randomized Controlled Trial Investigating the Efficacy and Safety of Nebulized Heparin Versus Placebo in Burn Patients With Inhalation Trauma (Hepburn)

Sponsor

Source record

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase

Source record

PHASE3

Modality

AI-normalized

small molecule

Target

AI-normalized

Inhalation trauma in burn patients

Indication / condition

AI-normalized

Inhalation Injury

Intervention

Source record

unfractionated heparin, placebo

Source & freshness

Source record

NCT ID

NCT01773083

Original source

ClinicalTrials.gov

Source last updated

Feb 16, 2022

Ingested at

May 23, 2026

Internal sync

Jun 05, 2026

Model version

trialsignal-ai-v1

Normalized confidence

88%

Validation status

validated

Open original registry record
View original source fields

NCT ID

NCT01773083

Title

Randomized Controlled Trial Investigating the Efficacy and Safety of Nebulized Heparin Versus Placebo in Burn Patients With Inhalation Trauma (Hepburn)

Sponsor

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Status

TERMINATED

Phase

PHASE3

Condition raw

Inhalation Injury

Condition normalized

Inhalation Injury

Modality raw

Inhalation Injury

Modality normalized

small molecule

Target raw

Inhalation trauma in burn patients

Target normalized

Inhalation trauma in burn patients

Interventions

unfractionated heparin, placebo

Public preview

Source record

The trial aimed to evaluate the efficacy and safety of nebulized heparin compared to placebo in burn patients with inhalation trauma requiring mechanical ventilation. The study was terminated due to insufficient patient recruitment and high costs.

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Full protocol, outcomes, eligibility, contacts and results sections
Patent/IP landscape with verified records when available
Board-ready PDF export with source provenance
Save to folders and synthesize multiple assets in premium workspace
Create account
Sign in

Create a free account first, then unlock a single report, buy credits or subscribe.

TrialSignal

Clinical trial intelligence report

Randomized Controlled Trial Investigating the Efficacy and Safety of Nebulized Heparin Versus Placebo in Burn Patients With Inhalation Trauma (Hepburn)

Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.

Generated

Jun 13, 2026

NCT ID

NCT01773083

Status

TERMINATED

Phase

PHASE3

Sponsor

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Executive brief

Investment-Ready Snapshot

The trial aimed to evaluate the efficacy and safety of nebulized heparin compared to placebo in burn patients with inhalation trauma requiring mechanical ventilation. The study was terminated due to insufficient patient recruitment and high costs.

Source & freshness

Provenance

SourceClinicalTrials.gov
Source updatedFeb 16, 2022
Internal syncJun 05, 2026
Model versiontrialsignal-ai-v1

https://clinicaltrials.gov/study/NCT01773083

Indication

Inhalation Injury

Modality

small molecule

Target

Inhalation trauma in burn patients

Intervention

unfractionated heparin, placebo

Source record

Protocol Description

Detailed source ingestion pending.

Source record

Outcome Measures

Detailed source ingestion pending.

Source record

Eligibility

Detailed source ingestion pending.

AI analysis

Known Results And Readout Context

Detailed source ingestion pending.

IP intelligence

Patent And IP Landscape

Detailed source ingestion pending.

Source record

Contacts

Detailed source ingestion pending.